Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Panel adopts Senate amendments and passes prescription-drug affordability bill with rare-disease guardrails
Summary
The Insurance and Pharmaceuticals Subcommittee unanimously adopted Senate amendments to Senate Bill 357 and passed the bill, which expands board authority, adds stakeholder seats and reporting requirements, and requires extra consideration of impacts on patients with rare diseases.
Madam Chair convened the Insurance and Pharmaceuticals Subcommittee and opened consideration of Senate Bill 357, a prescription drug affordability measure cross-filed as House Bill 424. Lisa, a committee staff member, told members the Senate added three stakeholder-council seats — a representative of the rare-disease community, an oncologist and a patient-advocacy representative — and added reporting…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
